Correction to: Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model
BMC Nephrol
.
2020 Jul 16;21(1):278.
doi: 10.1186/s12882-020-01933-3.
Authors
Kyle Hayes
1
,
Elizabeth Warner
2
,
Chris Bollinger
2
,
Dale Wright
2
,
Richard M Fitch
2
Affiliations
1
Mallinckrodt Pharmaceuticals, 675 James S. McDonnell Blvd, 20-1-W, Hazelwood, MO, USA. Kyle.Hayes@mnk.com.
2
Mallinckrodt Pharmaceuticals, 675 James S. McDonnell Blvd, 20-1-W, Hazelwood, MO, USA.
PMID:
32677914
PMCID:
PMC7364518
DOI:
10.1186/s12882-020-01933-3
Abstract
An amendment to this paper has been published and can be accessed via the original article.
Publication types
Published Erratum